Parnassus Fund Adds $125M AstraZeneca Stake, Boosts JPMorgan by 15%
Parnassus Value Equity Fund added 634,492 AstraZeneca PLC shares valued at $125.13 million, plus 678,208 Boston Scientific shares worth $42.56 million, in Q1 2026. The fund also increased JPMorgan Chase shares by 14.59% to 572,217 ($168.32M), boosted Waste Management by 28.59% ($85.07M), and exited three holdings.
1. Major Addition of AstraZeneca PLC
Parnassus Value Equity Fund acquired 634,492 AstraZeneca PLC shares valued at $125.13 million, representing 2.73% of its portfolio during Q1 2026.
2. New Position in Boston Scientific
The fund added 678,208 shares of Boston Scientific Corp worth $42.56 million, comprising approximately 0.93% of its holdings.
3. Significant Increases in JPMorgan and Waste Management
Parnassus boosted its JPMorgan Chase & Co stake by 72,858 shares (14.59% increase), now holding 572,217 shares valued at $168.32 million, and added 82,299 Waste Management Inc shares (28.59% increase) valued at $85.07 million.
4. Full Exits of Three Holdings
During Q1 2026, the fund entirely liquidated three unspecified positions as part of its portfolio realignment.